Company Profile

Verax Corporation
Profile last edited on: 6/9/15      CAGE:       UEI:

Business Identifier: Biotechnology research & development
Year Founded
----
First Award
1981
Latest Award
1989
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

8 Commerce Avenue Unit 4
West Lebanon, NH 03784
   (603) 448-4445
   N/A
   N/A
Location: Single
Congr. District: 02
County: Grafton

Public Profile

A very active SBIR player in the early days of the program, in 1993, Verax was acquired by Creative BioMolecules, itself an active SBIR Awardee. Creative BioMolecules has subsequently merged with another SBIR firm and with a third firm (not SBIR-involved) to found the publicly traded entity Curis.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
N/A
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1989 1 NIH $50,000
Project Title: Production of HIV gp-120 Protein by Recombinant HeLa Cells in Collagen Microspheres
1988 1 NIH $50,000
Project Title: Defined media for continuous culture of mammalian cells
1987 2 NSF $249,895
Project Title: Mathematical Modeling of Mammalian Cells
1987 1 NIH $50,000
Project Title: Improved system for mass culture of human hybridomas
1986 1 NIH $50,000
Project Title: Tumor immunotherapy & human hybridoma culture

Key People / Management

  Peter L Christie

  Edward G Hayman

  Philip Phillips

  Amar S Tung

  Sotirios Vahaviolos

  Margaret Worden

Company News

There are no news available.